Structured evidence table for Reishi Stress Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Reishi Stress Randomized Trial | It also critically evaluates the current level of evidence and highlights key limitations related to standardization, variability of extracts, and clinical applicability. | 3 | Sadowska Anna (2026) | Medicinal Mushrooms and Their Bioactive Compounds: From Traditional Use to Therapeutic Potential |
| Reishi Stress Randomized Trial | Notably, a fungus calledwas found among the belongings of the world’s oldest human mummy, estimated to be about 4000 years old. | 3 | Sadowska Anna (2026) | Medicinal Mushrooms and Their Bioactive Compounds: From Traditional Use to Therapeutic Potential |
| Reishi Stress Randomized Trial | Ganoderma lucidum In Chinese culture, lingzhi () was celebrated as a superior tonic and a symbol of spiritual power and immortality, and was regarded as the “herb of spiritual potency,” associated with success, well-being, divine power, and long life. | 3 | Sadowska Anna (2026) | Medicinal Mushrooms and Their Bioactive Compounds: From Traditional Use to Therapeutic Potential |
| Reishi Stress Randomized Trial | 1 Approximately 2.2 to 3.8 million fungal species have been identified worldwide, with about 2000 regarded as edible and over 200 recognized for their medicinal properties. | 3 | Sadowska Anna (2026) | Medicinal Mushrooms and Their Bioactive Compounds: From Traditional Use to Therapeutic Potential |
| Reishi Stress Randomized Trial | lucidum There appears to be an accumulating body of evidence for the complementary metabolic actions of these components in experimental diabetes models. | 3 | Florea Bogdan (2026) | Ganoderma lucidum as a Functional Bioactive Candidate for Glycemic Regulation: Mechanisms, Preclinical Evidence, and Clinical Translation |
| Reishi Stress Randomized Trial | Ganoderma polysaccharides and proteoglycan fractions have been associated with improved insulin signaling, peripheral glucose uptake, AMPK activation, and modulation of hepatic glucose output [,,,,]. | 3 | Florea Bogdan (2026) | Ganoderma lucidum as a Functional Bioactive Candidate for Glycemic Regulation: Mechanisms, Preclinical Evidence, and Clinical Translation |
| Reishi Stress Randomized Trial | In particular, this review critically aligns taxonomic authentication, tissue source, extraction method, polysaccharide and triterpenoid standardization, mechanism-level evidence, and clinical trial limitations within a single glycemic regulation framework. | 3 | Florea Bogdan (2026) | Ganoderma lucidum as a Functional Bioactive Candidate for Glycemic Regulation: Mechanisms, Preclinical Evidence, and Clinical Translation |
| Reishi Stress Randomized Trial | lucidum 1 2 3 4 The increasing worldwide prevalence of type 2 diabetes mellitus (T2DM) has further propelled interest in the search for safe and multi-target nutraceuticals as potential adjuncts to existing treatments.(GL), a polypore fungus in the family of basidiomycetes, has been used in traditional medicines in the ancient East for many centuries []. | 3 | Florea Bogdan (2026) | Ganoderma lucidum as a Functional Bioactive Candidate for Glycemic Regulation: Mechanisms, Preclinical Evidence, and Clinical Translation |
Source documents